Annual Total Debt
$1.03 M
-$246.80 K-19.37%
December 31, 2023
Summary
- As of February 12, 2025, GANX annual total debt is $1.03 million, with the most recent change of -$246.80 thousand (-19.37%) on December 31, 2023.
- During the last 3 years, GANX annual total debt has fallen by -$234.00 thousand (-18.55%).
- GANX annual total debt is now -36.13% below its all-time high of $1.61 million, reached on December 31, 2021.
Performance
GANX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$769.50 K
-$38.10 K-4.72%
September 30, 2024
Summary
- As of February 12, 2025, GANX quarterly total debt is $769.50 thousand, with the most recent change of -$38.10 thousand (-4.72%) on September 30, 2024.
- Over the past year, GANX quarterly total debt has dropped by -$257.90 thousand (-25.10%).
- GANX quarterly total debt is now -52.16% below its all-time high of $1.61 million, reached on December 1, 2021.
Performance
GANX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
GANX Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.4% | -25.1% |
| 3 y3 years | -18.6% | -52.2% |
| 5 y5 years | +100.0% | -52.2% |
GANX Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -36.1% | at low | -52.2% | at low |
| 5 y | 5-year | -36.1% | +411.4% | -52.2% | -100.0% |
| alltime | all time | -36.1% | -100.0% | -52.2% | -100.0% |
Gain Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $769.50 K(-4.7%) |
| Jun 2024 | - | $807.60 K(-9.2%) |
| Mar 2024 | - | $889.60 K(-13.4%) |
| Dec 2023 | $1.03 M(-19.4%) | $1.03 M(-1.1%) |
| Sep 2023 | - | $1.04 M(-9.2%) |
| Jun 2023 | - | $1.14 M(-5.1%) |
| Mar 2023 | - | $1.21 M(-5.4%) |
| Dec 2022 | $1.27 M(-20.8%) | $1.27 M(+0.4%) |
| Sep 2022 | - | $1.27 M(-8.5%) |
| Jun 2022 | - | $1.39 M(-7.3%) |
| Mar 2022 | - | $1.50 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $1.61 M(+27.5%) | - |
| Dec 2021 | - | $1.61 M(+10.7%) |
| Sep 2021 | - | $1.45 M(-4.7%) |
| Jun 2021 | - | $1.52 M(+24.8%) |
| Mar 2021 | - | $1.22 M(-3.2%) |
| Dec 2020 | $1.26 M(+527.9%) | - |
| Dec 2020 | - | $1.26 M(>+9900.0%) |
| Sep 2020 | - | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00 |
| Dec 2019 | $200.90 K(>+9900.0%) | - |
| Dec 2018 | $0.00 | - |
FAQ
- What is Gain Therapeutics annual total debt?
- What is the all time high annual total debt for Gain Therapeutics?
- What is Gain Therapeutics annual total debt year-on-year change?
- What is Gain Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Gain Therapeutics?
- What is Gain Therapeutics quarterly total debt year-on-year change?
What is Gain Therapeutics annual total debt?
The current annual total debt of GANX is $1.03 M
What is the all time high annual total debt for Gain Therapeutics?
Gain Therapeutics all-time high annual total debt is $1.61 M
What is Gain Therapeutics annual total debt year-on-year change?
Over the past year, GANX annual total debt has changed by -$246.80 K (-19.37%)
What is Gain Therapeutics quarterly total debt?
The current quarterly total debt of GANX is $769.50 K
What is the all time high quarterly total debt for Gain Therapeutics?
Gain Therapeutics all-time high quarterly total debt is $1.61 M
What is Gain Therapeutics quarterly total debt year-on-year change?
Over the past year, GANX quarterly total debt has changed by -$257.90 K (-25.10%)